Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.
about
A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease.Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies.Application of calibrated fMRI in Alzheimer's disease.Neuroimaging tests for clinical psychiatry: Are we there yet?Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.Advances in arterial spin labelling MRI methods for measuring perfusion and collateral flow.Alzheimer's disease severity, objectively determined and measured.Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology.Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease.MRI assessment of whole-brain structural changes in aging.Pericortical Enhancement on Delayed Postgadolinium Fluid-Attenuated Inversion Recovery Images in Normal Aging, Mild Cognitive Impairment, and Alzheimer Disease.Plasma cytokine IL-6 levels and subjective cognitive decline: preliminary findings.The Cognitive decline in Older Patients with End stage renal disease (COPE) study - rationale and design.Early-onset and delayed-onset poststroke dementia - revisiting the mechanisms.Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides.Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease.Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis.Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.A clinicopathological approach to the diagnosis of dementia.Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease.Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer's disease.Impaired hypoxic tolerance in APP23 mice: a dysregulation of neuroprotective globin levels.'Alzheimer's Progression Score': Development of a Biomarker Summary Outcome for AD Prevention TrialsMicrovascular ultrastructural changes precede cognitive impairment in the murine APPswe/PS1dE9 model of Alzheimer's disease.Validation of T1w-based segmentations of white matter hyperintensity volumes in large-scale datasets of aging.Alzheimer's disease: A matter of blood-brain barrier dysfunction?Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET.Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway.Pericyte implantation in the brain enhances cerebral blood flow and reduces amyloid-β pathology in amyloid model mice.Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.Multiscale modelling of blood flow in cerebral microcirculation: Details at capillary scale control accuracy at the level of the cortex.Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Vitamin D and the Risk of Dementia: The Rotterdam Study.Enhancement of automated blood flow estimates (ENABLE) from arterial spin-labeled MRI.A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review.Detrimental effect of systemic vascular risk factors on brain hemodynamic function assessed with MRI.
P2860
Q30235315-03C41253-97DE-4338-A03C-F3F7C0366164Q30854541-350EEAEC-D0C2-4E4D-B3CA-7EFEE7752820Q33555571-97EB0EE1-5360-4D00-B900-594DF79BE4F3Q33714234-14646C70-5651-4440-842E-E30AED12559BQ33726147-1D100779-92AA-488D-86B5-CDD9BB8B325CQ33842681-4EF00B67-C812-474D-8491-83DA4D3FC6EBQ36335013-A0871EB9-81CE-4327-AB75-3D5C7D562E34Q36396660-C3B7B41C-75BF-4E93-A5A1-D05C884196D0Q37363931-997DC2F8-D48E-4F4C-9418-8BDFDAE372C7Q37396195-DF0522EB-CE5F-43AA-BC92-F048B7897883Q37654110-0F484EB4-2366-4C72-820E-6695971C41C2Q38604991-6EF107B2-C8C8-4F1D-8A06-1F4697175C4CQ38661720-A5ABA81C-640B-4456-9E73-AB0B5E8C06A5Q38668100-71300265-004E-4218-95EF-B5BD82899B40Q38730795-31EF59F8-BF6C-42C4-AD74-5C7E698EA207Q38756224-08963E77-6F2B-44A7-91D2-7F1F860D2879Q38780279-5D2F3B0A-0960-4AA8-81C6-5E10FA3BBFA8Q39041998-060A0775-3EC2-4289-B5AD-7A2683A2040BQ39301541-4B29D496-53C2-4A3D-8F45-07D365F1D192Q39313671-AFA2A3ED-A516-4317-AB38-39F95F7D94C4Q39434968-BAB8CEA1-8FE9-4BE3-B28D-A0776B2E3337Q39444002-2BF97E59-900E-4343-856F-C8C70BDCE3BCQ40193607-38802691-AEE5-493B-88DC-9716CE981142Q42334782-672844CD-0E8C-4428-A251-F7B70AB28768Q42376619-6AF90141-5F64-4D17-BE61-51BA8349B7A7Q43249667-654FA982-B66D-43D0-8411-B1E6AC530BF9Q45942978-C3041A34-712A-4806-9C8F-40A614D82FCBQ46165463-D8AEB469-727A-483D-8358-8226E752CB30Q46254853-F895A56A-EBA9-4671-9C05-00D972D5BFAEQ46398713-99D158E4-6978-436E-81F3-4328E365C187Q47096954-8B4B1BDE-C8B6-4C4E-81E3-B7FD86523706Q47201004-CAAD9655-334B-436F-8119-91D0AD789BAEQ47437348-2B35698D-0012-4590-96F7-6F0B268FA51DQ47707801-32F613C9-B18C-4C62-A5CF-8E1D0E907186Q47737999-AA62EFA3-AEEF-482B-B3F5-089A72B0890CQ47743028-3B83B1D2-7B56-4EDC-994D-0E6737AC8E4BQ47747850-23C5CF28-EC30-4F2B-8776-D2AE01BACFB9Q47775881-282AC2FF-8B4E-4EC0-9354-AA3CF45DC249Q47872250-1856C745-815B-450E-989A-ED19CA898B22Q47872692-06EB91FD-CE30-4BBC-838C-568FEA342E60
P2860
Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Early role of vascular dysregu ...... actorial data-driven analysis.
@ast
Early role of vascular dysregu ...... actorial data-driven analysis.
@en
type
label
Early role of vascular dysregu ...... actorial data-driven analysis.
@ast
Early role of vascular dysregu ...... actorial data-driven analysis.
@en
prefLabel
Early role of vascular dysregu ...... actorial data-driven analysis.
@ast
Early role of vascular dysregu ...... actorial data-driven analysis.
@en
P2093
P2860
P356
P1476
Early role of vascular dysregu ...... actorial data-driven analysis.
@en
P2093
J M Mateos-Pérez
P J Toussaint
R C Sotero
Y Iturria-Medina
P2860
P2888
P356
10.1038/NCOMMS11934
P407
P577
2016-06-21T00:00:00Z
P6179
1041170285